Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Shimizu

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Psychiatry and Clinical Neurosciences|May 30, 2023
Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double-blind, randomized, placebo-controlled, phase 2 clinical trialMasaki Kato, Kazuyuki Nakagome, Takamichi Baba, et al.
Optics Express|June 13, 2014
Pulsed Sagnac polarization-entangled photon source with a PPKTP crystal at telecom wavelengthRui-Bo Jin, Ryosuke Shimizu, Kentaro Wakui, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|February 23, 2026
Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trialMasaki Kato, Kazuyuki Nakagome, Takamichi Baba, et al.
The British Journal of Dermatology|October 23, 2024
Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week randomized double-blind placebo-controlled phase III trial in Japan (ADhere-J)Norito Katoh, Akio Tanaka, Hidetoshi Takahashi, et al.
Psychiatry and Clinical Neurosciences|May 20, 2026
Response to Durability of zuranolone in postpartum depression versus major depressive disorderMasaki Kato, Kazuyuki Nakagome, Takamichi Baba, et al.
European Journal of Preventive Cardiology|June 1, 2013
Quadriceps isometric strength as a predictor of exercise capacity in coronary artery disease patientsKentaro Kamiya, Alessandro Mezzani, Kazuki Hotta, et al.
Psychiatry and Clinical Neurosciences|November 18, 2025
Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double-blind, randomized, placebo-controlled, Phase 3 clinical trialMasaki Kato, Kazuyuki Nakagome, Takamichi Baba, et al.
Acta Dermato-Venereologica|September 9, 2024
Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic DermatitisAkio Tanaka, Ken Igawa, Hidetoshi Takahashi, et al.
Respiratory Physiology & Neurobiology|July 19, 2011
Effects of prolonged expiration breathing on cardiopulmonary responses during incremental exerciseTakuya Matsumoto, Takashi Masuda, Kazuki Hotta, et al.
International Heart Journal|June 6, 2014
Six-minute walk distance is an independent predictor of hospital readmission in patients with chronic heart failureMinoru Tabata, Ryosuke Shimizu, Daisuke Kamekawa, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Psychiatry and Clinical Neurosciences|May 30, 2023
Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double-blind, randomized, placebo-controlled, phase 2 clinical trialMasaki Kato, Kazuyuki Nakagome, Takamichi Baba, et al.
Optics Express|June 13, 2014
Pulsed Sagnac polarization-entangled photon source with a PPKTP crystal at telecom wavelengthRui-Bo Jin, Ryosuke Shimizu, Kentaro Wakui, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|February 23, 2026
Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trialMasaki Kato, Kazuyuki Nakagome, Takamichi Baba, et al.
The British Journal of Dermatology|October 23, 2024
Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week randomized double-blind placebo-controlled phase III trial in Japan (ADhere-J)Norito Katoh, Akio Tanaka, Hidetoshi Takahashi, et al.
Psychiatry and Clinical Neurosciences|May 20, 2026
Response to Durability of zuranolone in postpartum depression versus major depressive disorderMasaki Kato, Kazuyuki Nakagome, Takamichi Baba, et al.
European Journal of Preventive Cardiology|June 1, 2013
Quadriceps isometric strength as a predictor of exercise capacity in coronary artery disease patientsKentaro Kamiya, Alessandro Mezzani, Kazuki Hotta, et al.
Psychiatry and Clinical Neurosciences|November 18, 2025
Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double-blind, randomized, placebo-controlled, Phase 3 clinical trialMasaki Kato, Kazuyuki Nakagome, Takamichi Baba, et al.
Acta Dermato-Venereologica|September 9, 2024
Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic DermatitisAkio Tanaka, Ken Igawa, Hidetoshi Takahashi, et al.
Respiratory Physiology & Neurobiology|July 19, 2011
Effects of prolonged expiration breathing on cardiopulmonary responses during incremental exerciseTakuya Matsumoto, Takashi Masuda, Kazuki Hotta, et al.
International Heart Journal|June 6, 2014
Six-minute walk distance is an independent predictor of hospital readmission in patients with chronic heart failureMinoru Tabata, Ryosuke Shimizu, Daisuke Kamekawa, et al.
Pageof 8